SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

被引：355

作者：

Corbett, Kizzmekia S. ^{[1
]}

Edwards, Darin K. ^{[2
]}

Leist, Sarah R. ^{[3
]}

Abiona, Olubukola M. ^{[1
]}

Boyoglu-Barnum, Seyhan ^{[1
]}

Gillespie, Rebecca A. ^{[1
]}

Himansu, Sunny ^{[2
]}

Schafer, Alexandra ^{[3
]}

Ziwawo, Cynthia T. ^{[1
]}

DiPiazza, Anthony T. ^{[1
]}

Dinnon, Kenneth H. ^{[3
]}

Elbashir, Sayda M. ^{[2
]}

Shaw, Christine A. ^{[2
]}

Woods, Angela ^{[2
]}

Fritch, Ethan J. ^{[4
]}

Martinez, David R. ^{[3
]}

Bock, Kevin W. ^{[5
]}

Minai, Mahnaz ^{[5
]}

Nagata, Bianca M. ^{[5
]}

Hutchinson, Geoffrey B. ^{[1
]}

Wu, Kai ^{[2
]}

Henry, Carole ^{[2
]}

Bahl, Kapil

Garcia-Dominguez, Dario ^{[2
]}

Ma, LingZhi ^{[2
]}

Renzi, Isabella ^{[2
]}

Kong, Wing-Pui ^{[1
]}

Schmidt, Stephen D. ^{[1
]}

Wang, Lingshu ^{[1
]}

Zhang, Yi ^{[1
]}

Phung, Emily ^{[1
,6
]}

Chang, Lauren A. ^{[1
]}

Loomis, Rebecca J. ^{[1
]}

Altaras, Nedim Emil ^{[2
]}

Narayanan, Elisabeth ^{[2
]}

Metkar, Mihir ^{[2
]}

Presnyak, Vlad ^{[2
]}

Liu, Cuiping ^{[1
]}

Louder, Mark K. ^{[1
]}

Shi, Wei ^{[1
]}

Leung, Kwanyee ^{[1
]}

Yang, Eun Sung ^{[1
]}

West, Ande ^{[3
]}

Gully, Kendra L. ^{[3
]}

Stevens, Laura J. ^{[7
]}

Gully, Kendra L. ^{[3
]}

Wang, Nianshuang ^{[8
]}

Wrapp, Daniel ^{[8
]}

Doria-Rose, Nicole A. ^{[1
]}

Stewart-Jones, Guillaume ^{[2
]}

机构：

[1] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[2] Moderna Inc, Cambridge, MA USA

[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA

[4] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA

[5] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[6] George Washington Univ, Inst Biomed Sci, Washington, DC USA

[7] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA

[8] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA

[9] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

来源：

NATURE | 2020年 / 586卷 / 7830期

关键词：

MERS-COV; SPIKE; INFLUENZA; IMMUNOGENICITY; PROTECTION; VIRUS; RSV;

D O I：

10.1038/s41586-020-2622-0

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have led to the development of mutations that stabilize Betacoronavirus spike proteins in the prefusion state, improving their expression and increasing immunogenicity(1). This principle has been applied to design mRNA-1273, an mRNA vaccine that encodes a SARS-CoV-2 spike protein that is stabilized in the prefusion conformation. Here we show that mRNA-1273 induces potent neutralizing antibody responses to both wild-type (D614) and D614G mutant(2) SARS-CoV-2 as well as CD8(+) T cell responses, and protects against SARS-CoV-2 infection in the lungs and noses of mice without evidence of immunopathology. mRNA-1273 is currently in a phase III trial to evaluate its efficacy.

引用

页码：567 / +

页数：21

共 50 条

[1] SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett
Darin K. Edwards
Sarah R. Leist
Olubukola M. Abiona
Seyhan Boyoglu-Barnum
Rebecca A. Gillespie
Sunny Himansu
Alexandra Schäfer
Cynthia T. Ziwawo
Anthony T. DiPiazza
Kenneth H. Dinnon
Sayda M. Elbashir
Christine A. Shaw
Angela Woods
Ethan J. Fritch
David R. Martinez
Kevin W. Bock
Mahnaz Minai
Bianca M. Nagata
Geoffrey B. Hutchinson
Kai Wu
Carole Henry
Kapil Bahl
Dario Garcia-Dominguez
LingZhi Ma
Isabella Renzi
Wing-Pui Kong
Stephen D. Schmidt
Lingshu Wang
Yi Zhang
Emily Phung
Lauren A. Chang
Rebecca J. Loomis
Nedim Emil Altaras
Elisabeth Narayanan
Mihir Metkar
Vlad Presnyak
Cuiping Liu
Mark K. Louder
Wei Shi
Kwanyee Leung
Eun Sung Yang
Ande West
Kendra L. Gully
Laura J. Stevens
Nianshuang Wang
Daniel Wrapp
Nicole A. Doria-Rose
Guillaume Stewart-Jones
Hamilton Bennett
Nature, 2020, 586 : 567 - 571
[2] SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S Corbett
四川生理科学杂志, 2020, 42 (03) : 280 - 280
[3] Design and Preclinical Evaluation of a Universal SARS-CoV-2 mRNA Vaccine
Langston, Laura Katherine
Xu, Renhuan
Zhu, Huabin
Qin, Jane
Jeon, Ju
Xu, Jiangsheng
Mou, Stephanie
JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
[4] Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
Qin, Jane
Jeon, Ju Hyeong
Xu, Jiangsheng
Langston, Laura Katherine
Marasini, Ramesh
Mou, Stephanie
Montoya, Brian
Melo-Silva, Carolina R.
Jeon, Hyo Jin
Zhu, Tianyi
Sigal, Luis J.
Xu, Renhuan
Zhu, Huabin
FRONTIERS IN IMMUNOLOGY, 2023, 14
[5] A SARS-CoV-2 mRNA Vaccine - Preliminary Report
Jackson, Lisa A.
Roberts, Paul C.
Graham, Barney S.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (12): : 1190 - 1192
[6] Circular mRNA Vaccine against SARS-COV-2 Variants Enabled by Degradable Lipid Nanoparticles
Huang, Ke
Li, Na
Li, Yingwen
Zhu, Jiafeng
Fan, Qianyi
Yang, Jiali
Gao, Yinjia
Liu, Yuping
Gao, Shufeng
Zhao, Peng
Wei, Ke
Deng, Chao
Zuo, Chijian
Sun, Zhenhua
ACS APPLIED MATERIALS & INTERFACES, 2025, 17 (03) : 4699 - 4710
[7] Design and development of a multi-epitope vaccine prototype against SARS-CoV-2
Tchorbanov, Andrey
Ralchev, Nikola
Manoylov, Iliyan
Bradyanova, Silviya
Mihaylova, Nikolina
Doytchinova, Irini
Tcholakova, Slavka
EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1433 - 1433
[8] Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS-CoV-2 and variants
Su, Peng
Zhang, Lei
Zhou, Fangfang
Zhang, Long
MEDCOMM, 2022, 3 (03):
[9] Immunophenotyping of SARS-CoV-2 and vaccine design
Cimolai, Nevio
VACCINE, 2022, 40 (30) : 3985 - 3986
[10] Immunophenotyping of SARS-CoV-2 and vaccine design
Cimolai, Nevio
VACCINE, 2022, 40 (29) : 3985 - 3986

← 1 2 3 4 5 →